Previous Article | Next Article 
Molecular and Cellular Biology, April 2005, p. 3286-3294, Vol. 25, No. 8
0270-7306/05/$08.00+0 doi:10.1128/MCB.25.8.3286-3294.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
The SR Protein SC35 Is Responsible for Aberrant Splicing of the E1
Pyruvate Dehydrogenase mRNA in a Case of Mental Retardation with Lactic Acidosis
Mathieu Gabut,1,
Manuèle Miné,2,
Cécile Marsac,2
Michèle Brivet,3
Jamal Tazi,1* and
Johann Soret1
Institut de Génétique Moléculaire de Montpellier-UMR5535-IFR122, CNRS, Montpellier,1
Centre de Recherches Thérapeutiques en Ophtalmologie, Faculté de Médecine Necker, Paris,2
Biochimie 1, Hôpital de Bicêtre, Le Kremlin Bicêtre, France3
Received 6 December 2004/
Returned for modification 4 January 2005/
Accepted 14 January 2005
Pyruvate dehydrogenase (PDH) complex deficiency is a major cause of lactic acidosis and Leigh's encephalomyelopathies in infancy and childhood, resulting in early death in the majority of patients. Most of the molecular defects have been localized in the coding regions of the E1
PDH gene. Recently, we identified a novel mutation of the E1
PDH gene in a patient with an encephalopathy and lactic acidosis. This mutation, located downstream of exon 7, activates a cryptic splice donor and leads to the retention of intronic sequences. Here, we demonstrate that the mutation results in an increased binding of the SR protein SC35. Consistently, ectopic overexpression of this splicing factor enhanced the use of the cryptic splice site, whereas small interfering RNA-mediated reduction of the SC35 protein levels in primary fibroblasts from the patient resulted in the almost complete disappearance of the aberrantly spliced E1
PDH mRNA. Our findings open the exciting prospect for a novel therapy of an inherited disease by altering the level of a specific splicing factor.
* Corresponding author. Mailing address: UMR 5535, IFR122, CNRS-UMII, Institut de Génétique Moléculaire de Montpellier, 1919 route de Mende, 34293 Montpellier, France. Phone: 33 (0) 467613685. Fax: 33 (0) 467040231. E-mail:
tazi{at}igmm.cnrs.fr.
M.G. and M.M. contributed equally to this work.
Molecular and Cellular Biology, April 2005, p. 3286-3294, Vol. 25, No. 8
0022-538X/05/$08.00+0 doi:10.1128/MCB.25.8.3286-3294.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Palomino-Doza, J., Rahman, T. J., Avery, P. J., Mayosi, B. M., Farrall, M., Watkins, H., Edwards, C. R.W., Keavney, B.
(2008). Ambulatory Blood Pressure Is Associated With Polymorphic Variation in P2X Receptor Genes. Hypertension
52: 980-985
[Abstract]
[Full Text]
-
Suryavathi, V., Khattri, A., Gopal, K., Rani, D. S., Panneerdoss, S., Gupta, N. J., Chakravarty, B., Deenadayal, M., Singh, L., Thangaraj, K.
(2008). Novel Variants in UBE2B Gene and Idiopathic Male Infertility. J Androl
29: 564-571
[Abstract]
[Full Text]
-
Ram, O., Schwartz, S., Ast, G.
(2008). Multifactorial Interplay Controls the Splicing Profile of Alu-Derived Exons. Mol. Cell. Biol.
28: 3513-3525
[Abstract]
[Full Text]
-
Tran, V. K., Takeshima, Y., Zhang, Z., Yagi, M., Nishiyama, A., Habara, Y., Matsuo, M.
(2006). Splicing analysis disclosed a determinant single nucleotide for exon skipping caused by a novel intraexonic four-nucleotide deletion in the dystrophin gene. J. Med. Genet.
43: 924-930
[Abstract]
[Full Text]
-
Buratti, E., Baralle, M., Baralle, F. E.
(2006). Defective splicing, disease and therapy: searching for master checkpoints in exon definition. Nucleic Acids Res
34: 3494-3510
[Abstract]
[Full Text]
-
Spena, S., Tenchini, M. L., Buratti, E.
(2006). Cryptic splice site usage in exon 7 of the human fibrinogen B{beta}-chain gene is regulated by a naturally silent SF2/ASF binding site within this exon. RNA
12: 948-958
[Abstract]
[Full Text]
-
Wang, J., Smith, P. J., Krainer, A. R., Zhang, M. Q.
(2005). Distribution of SR protein exonic splicing enhancer motifs in human protein-coding genes. Nucleic Acids Res
33: 5053-5062
[Abstract]
[Full Text]
-
Soret, J., Bakkour, N., Maire, S., Durand, S., Zekri, L., Gabut, M., Fic, W., Divita, G., Rivalle, C., Dauzonne, D., Nguyen, C. H., Jeanteur, P., Tazi, J.
(2005). Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors. Proc. Natl. Acad. Sci. USA
102: 8764-8769
[Abstract]
[Full Text]